Vaccine development has historically been an expensive, yearslong endeavor, and often not a great business. WSJ's Denise Roland explains how the search for a coronavirus vaccine could change the dynamics of the industry.
don't worry if you don't have an account with us, we'll create one
[{"meta":{"author":"The Journal.","authorlink":""},"src":"https:\/\/chtbl.com\/track\/1F1B1F\/traffic.megaphone.fm\/WSJ6412754275.mp3","thumb":{"src":"https:\/\/images.lystnfm.com\/wp\/tr:n-app_thumbnail_medium\/https:\/\/megaphone.imgix.net\/podcasts\/b84f9932-8174-11e9-bbd8-7f261513f0c9\/image\/d84a4f4d55158df9d14f6f2d4b219a28.jpg?ixlib=rails-4.3.1&max-w=3000&max-h=3000&fit=crop&auto=format,compress"},"title":"How Coronavirus Could Change the Vaccine Business","link":"javascript:;","id":"item-456556"}]
